Literature DB >> 1831183

Cardiac hypertrophy due to pressure and volume overload: distinctly different biological phenomena?

M A Rossi1, S V Carillo.   

Abstract

Myocardial hypertrophy is a morphological adaptive response to chronic work overload imposed on the heart. It has been categorized into two distinct basic types: concentric hypertrophy, occurring in response to a sustained pressure overload in which wall thickness increases without chamber enlargement, and eccentric hypertrophy, in response to a chronic volume overload in which chamber volume enlarges without a relative increase in its wall thickness. It should be emphasized, in this context, that these adjectives are somewhat confusing, since the hypertrophy observed is not eccentric in the fashion often seen in the left ventricle of patients with hypertrophic cardiomyopathy. In fact, the hypertrophy is concentric in both instances, but is associated with an increase in chamber volume when described as eccentric, yet occurring with a maintained volume when said to be concentric. In rats made anemic by iron deficiency, the volume overloaded heart achieves an adaptive increase in mass characterized as hypertrophy occurring in the setting of dilated ventricle. This so-called eccentric hypertrophy depends on catecholamines as possible signals for myocardial growth, and progresses with preserved ultrastructure and contractile performance of the cardiac muscle. A gradually imposed volume overload results in a harmonious growth of the heart (it retains a relative normal shape, becoming a magnified normal heart), probably mediated by release of catecholamines into the myocardium. This process resembles the normal cardiac growth in response to the obligatory volume load imposed by an increasing cardiac output (greater metabolic demands) and blood volume.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1831183     DOI: 10.1016/0167-5273(91)90207-6

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model.

Authors:  Karina M Mata; Paula S Prudente; Fabio S Rocha; Cibele M Prado; Elaine M Floriano; Jorge Elias; Elen Rizzi; Raquel F Gerlach; Marcos A Rossi; Simone G Ramos
Journal:  Int J Exp Pathol       Date:  2010-10-29       Impact factor: 1.925

2.  Chronic hemodynamic unloading regulates the morphologic development of newborn mouse hearts transplanted into the ear of isogeneic adult mice.

Authors:  M A Rossi
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  A Serotonin 2A-Receptor Decoy Peptide Potently Lowers Blood Pressure in Male Zucker Diabetic, Fatty, Hypertensive Rats.

Authors:  Mark B Zimering
Journal:  Endocrinol Diabetes Metab J       Date:  2021-08-30

Review 4.  Emerging therapeutic targets for cardiac hypertrophy.

Authors:  Alexander J Winkle; Drew M Nassal; Rebecca Shaheen; Evelyn Thomas; Shivangi Mohta; Daniel Gratz; Seth H Weinberg; Thomas J Hund
Journal:  Expert Opin Ther Targets       Date:  2022-01-27       Impact factor: 6.902

Review 5.  Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy.

Authors:  Joana Silva; Paula A da Costa Martins
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

6.  Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.

Authors:  W Linz; J Schaper; G Wiemer; U Albus; B A Schölkens
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

7.  Resting Electrocardiogram and Blood Pressure in Young Endurance and Nonendurance Athletes and Nonathletes.

Authors:  Heikki Pentikäinen; Kerttu Toivo; Sami Kokko; Lauri Alanko; Olli J Heinonen; Raija Korpelainen; Harri Selänne; Tommi Vasankari; Urho M Kujala; Jari Villberg; Jari Parkkari; Kai Savonen
Journal:  J Athl Train       Date:  2021-05-01       Impact factor: 2.860

Review 8.  Melatonin in Heart Failure: A Promising Therapeutic Strategy?

Authors:  Frederic Nduhirabandi; Gerald J Maarman
Journal:  Molecules       Date:  2018-07-22       Impact factor: 4.411

9.  Unraveling the Mechanism of Cardiac Remodeling in Overloaded Heart: From Experiment to Theory.

Authors:  In Jeong Cho
Journal:  J Cardiovasc Imaging       Date:  2019-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.